FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alessandro Lugli

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Milo Horcic; Eva Karamitopoulou; Viktor H Koelzer; Giacomo Puppa; Luigi Terracciano; Inti Zlobec; Alessandro Lugli
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
E Karamitopoulou; A Kondi-Pafiti; D Born; Kostas Gennatas; B Gloor; P Lykoudis; A Mellou; Inti Zlobec; Alessandro Lugli
Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Eva Karamitopoulou; Viktor Kölzer; Agathi Kondi-Pafiti; Efstratios S Patsouris; Inti Zlobec; Kostas Gennatas; Alessandro Lugli
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alessandro Lugli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Milo Horcic; Eva Karamitopoulou; Viktor H Koelzer; Giacomo Puppa; Luigi Terracciano; Inti Zlobec; Alessandro Lugli
Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Human pathology 2013;44(5):697-705.
2013: E Karamitopoulou; A Kondi-Pafiti; D Born; Kostas Gennatas; B Gloor; P Lykoudis; A Mellou; Inti Zlobec; Alessandro Lugli
Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
European journal of cancer (Oxford, England : 1990) 2013;49(5):1032-9.
2013: Eva Karamitopoulou; Viktor Kölzer; Agathi Kondi-Pafiti; Efstratios S Patsouris; Inti Zlobec; Kostas Gennatas; Alessandro Lugli
Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013;26(2):295-301.
2012: Inti Zlobec; Alex Rufle; Michel P Bihl; Anja Foerster; Alessandro Lugli
The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer.
Histopathology 2012;61(5):777-87.
2012: Alessandro Lugli; E Karamitopoulou; Inti Zlobec
Tumour budding: a promising parameter in colorectal cancer.
British journal of cancer 2012;106(11):1713-7.
2012: Inti Zlobec; Alessandro Lugli; Markus Borner; Daniel Inderbitzin
Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.
International journal of surgical oncology 2012;2012():795945.
2012: Inti Zlobec; Michel P Bihl; Anja Foerster; Alex Rufle; Luigi Terracciano; Alessandro Lugli
Stratification and Prognostic Relevance of Jass's Molecular Classification of Colorectal Cancer.
Frontiers in oncology 2012;2():7.
2011: Alessandro Lugli; Efstratios S Patsouris; George Peros; Luigi M Terracciano; Tatjana Vlajnic; Olivier Giger; Eva Karamitopoulou; Inti Zlobec
Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Human pathology 2011;42(12):1833-40.
2011: Inti Zlobec; Alex Rufle; Michel P Bihl; Anja Foerster; Alessandro Lugli
Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
The Journal of pathology 2011;225(3):336-43.
2011: Tatjana Vlajnic; Inti Zlobec; Luigi Tornillo; Maria Carla Andreozzi; Eva Karamitopoulou; Alessandro Lugli; Christian Ruiz; Sandra Schneider; Luigi Terracciano
VEGFA gene locus (6p12) amplification identifies a small but highly aggressive subgroup of colorectal cancer [corrected] patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(10):1404-12.
2011: Inti Zlobec; Kristi Baker; Parham Minoo; Luigi Terracciano; Alessandro Lugli
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
Histopathology 2011;59(3):482-95.
2011: Giuseppe Sconocchia; Inti Zlobec; Alessandro Lugli; Diego Calabrese; Giandomenica Iezzi; Eva Karamitopoulou; Efstratios S Patsouris; George Peros; Milo Horcic; Luigi Tornillo; Markus Zuber; Raoul Droeser; Manuele G Muraro; Chantal Mengus; Daniel Oertli; Soldano Ferrone; Luigi Terracciano; Giulio C Spagnoli
Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma.
International journal of cancer. Journal international du cancer 2011;128(11):2663-72.
2011: Alessandro Lugli; Massimiliano Clemenza; Philip E Corso; Jacques di Costanzo; Richard Dirnhofer; Ettore Fiorini; Costanza Herborg; John Thomas Hindmarsh; Edoardo Orvini; Adalberto Piazzoli; Ezio Previtali; Angela Santagostino; Amnon Sonnenberg; Robert M Genta
The medical mystery of Napoleon Bonaparte: an interdisciplinary exposé.
Advances in anatomic pathology 2011;18(2):152-8.
2011: E Karamitopoulou; Inti Zlobec; Es Patsouris; G Peros; Alessandro Lugli
Loss of E-cadherin independently predicts the lymph node status in colorectal cancer.
Pathology 2011;43(2):133-7.
2011: Claude A Fischer; Minoa Jung; Inti Zlobec; Edith Green; Claudio Storck; Luigi Tornillo; Alessandro Lugli; Markus Wolfensberger; Luigi M Terracciano
Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
Head & neck 2011;33(2):267-73.
2010: Inti Zlobec; Michal Kovac; Priska Erzberger; Francesca Molinari; Michel P Bihl; Alexander Rufle; Anja Foerster; Milo Frattini; Luigi Terracciano; Karl Heinimann; Alessandro Lugli
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer.
International journal of cancer. Journal international du cancer 2010;127(11):2569-75.
2010: Inti Zlobec; Alessandro Lugli
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
Oncotarget 2010;1(7):651-61.
2010: Inti Zlobec; Francesca Molinari; Vittoria Martin; Luca Mazzucchelli; Piercarlo Saletti; Rosangela Trezzi; Sara De Dosso; Tatjana Vlajnic; Milo Frattini; Alessandro Lugli
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.
World journal of gastroenterology : WJG 2010;16(38):4823-31.
2010: Alessandro Lugli; G Iezzi; I Hostettler; M G Muraro; V Mele; Luigi Tornillo; Vincenza Carafa; Giulio C Spagnoli; Luigi Terracciano; Inti Zlobec
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
British journal of cancer 2010;103(3):382-90.
2010: Inti Zlobec; Michel P Bihl; Heike Schwarb; Luigi Terracciano; Alessandro Lugli
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
International journal of cancer. Journal international du cancer 2010;127(2):367-80.
2010: Alessandro Lugli
Archaeology dig into the duodenal biopsy.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2010;42(7):470-1.
2010: Daniel M Frey; Raoul A Droeser; Carsten T Viehl; Inti Zlobec; Alessandro Lugli; Urs Zingg; Daniel Oertli; Christoph Kettelhack; Luigi Terracciano; Luigi Tornillo
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
International journal of cancer. Journal international du cancer 2010;126(11):2635-43.
2010: Claude A Fischer; Inti Zlobec; Edith Green; Simone Probst; Claudio Storck; Alessandro Lugli; Luigi Tornillo; Markus Wolfensberger; Luigi Terracciano
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
International journal of cancer. Journal international du cancer 2010;126(5):1256-62.
2010: Lsabel Hostettler; Inti Zlobec; Luigi Terracciano; Alessandro Lugli
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.
World journal of gastroenterology : WJG 2010;16(6):732-9.
2010: Inti Zlobec; F Molinari; M Kovac; Michel P Bihl; H J Altermatt; J Diebold; H Frick; M Germer; Milo Horcic; matteo montani; Gad Singer; H Yurtsever; A Zettl; Luigi Terracciano; L Mazzucchelli; Piercarlo Saletti; M Frattini; Karl Heinimann; Alessandro Lugli
Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients.
British journal of cancer 2010;102(1):151-61.
2010: Inti Zlobec; Eva Karamitopoulou; Luigi Terracciano; Salvatore Piscuoglio; Giandomenica Iezzi; Manuele Giuseppe Muraro; Giulio Spagnoli; Kristi Baker; Alexandar Tzankov; Alessandro Lugli
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
PloS one 2010;5(12):e14282.
2010: Inti Zlobec; Parham Minoo; Eva Karamitopoulou; George Peros; Efstratios S Patsouris; Frank Lehmann; Alessandro Lugli
Role of tumor size in the pre-operative management of rectal cancer patients.
BMC gastroenterology 2010;10():61.
2010: Manuela Eppenberger; Inti Zlobec; Daniel Baumhoer; Luigi Terracciano; Alessandro Lugli
Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
BMC cancer 2010;10():93.
2009: Inti Zlobec; Ursula Günthert; Luigi Tornillo; Giandomenica Iezzi; Daniel Baumhoer; Luigi Terracciano; Alessandro Lugli
Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer.
Histopathology 2009;55(5):564-75.
2009: H Adams; Alexandar Tzankov; Alessandro Lugli; Inti Zlobec
New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma.
Journal of clinical pathology 2009;62(11):986-97.
2009: Alessandro Lugli; E Karamitopoulou; I Panayiotides; Petros Karakitsos; G Rallis; G Peros; G Iezzi; Giulio C Spagnoli; Michel P Bihl; Luigi Terracciano; Inti Zlobec
CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.
British journal of cancer 2009;101(8):1382-92.
2009: Inti Zlobec; Kristi Baker; Parham Minoo; Shinichi Hayashi; Luigi Terracciano; Alessandro Lugli
Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Cancer 2009;115(17):4021-9.
2009: Inti Zlobec; Sylvia Höller; Luigi Tornillo; Luigi Terracciano; Alessandro Lugli
Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer.
Diseases of the colon and rectum 2009;52(6):1114-21.
2008: Inti Zlobec; Kristi Baker; Luigi Terracciano; S Peter; L Degen; C Beglinger; Alessandro Lugli
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer.
British journal of cancer 2008;99(10):1712-7.
2008: Claude Fischer; Inti Zlobec; Edith Stöckli; Simone Probst; Claudio Storck; Luigi Tornillo; Alessandro Lugli; Markus Wolfensberger; Luigi Terracciano
Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Human pathology 2008;39(10):1527-34.
2008: Inti Zlobec; Luigi Terracciano; Luigi Tornillo; U Günthert; T Vuong; Jeremy R Jass; Alessandro Lugli
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
Gut 2008;57(10):1413-9.
2008: Inti Zlobec; Luigi Terracciano; Alessandro Lugli
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3792-7.
2008: Inti Zlobec; Alessandro Lugli
Prognostic and predictive factors in colorectal cancer.
Journal of clinical pathology 2008;61(5):561-9.
2008: Inti Zlobec; Parham Minoo; Daniel Baumhoer; Kristi Baker; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Cancer 2008;112(3):495-502.
2008: Inti Zlobec; Té Vuong; Carolyn Corlies Compton; Alessandro Lugli; René P Michel; S Hayashi; Jeremy R Jass
Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
British journal of cancer 2008;98(2):450-6.
2008: Inti Zlobec; Kristi Baker; Parham Minoo; Jeremy R Jass; Luigi Terracciano; Alessandro Lugli
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):143-8.
2007: Inti Zlobec; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.
Virchows Archiv : an international journal of pathology 2007;451(4):763-9.
2007: Inti Zlobec; Russell Steele; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer.
Journal of clinical pathology 2007;60(10):1112-6.
2007: Inti Zlobec; Alessandro Lugli; Kristi Baker; S Roth; Parham Minoo; S Hayashi; Luigi Terracciano; Jeremy R Jass
Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
The Journal of pathology 2007;212(3):260-8.
2007: Parham Minoo; Inti Zlobec; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
American journal of clinical pathology 2007;127(5):820-7.
2007: Alessandro Lugli; Inti Zlobec; Kristi Baker; Parham Minoo; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
Journal of clinical pathology 2007;60(5):534-9.
2007: Inti Zlobec; Parham Minoo; Kristi Baker; David G Haegert; Karim Khetani; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(6):1101-7.
2007: Inti Zlobec; Té Vuong; S Hayashi; David G Haegert; Luigi Tornillo; Luigi Terracciano; Alessandro Lugli; J Jass
A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
British journal of cancer 2007;96(5):793-800.
2007: Alessandro Lugli; Inti Zlobec; Parham Minoo; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Histopathology 2007;50(4):453-64.
2007: Parham Minoo; Inti Zlobec; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(3):331-8.
2007: Coya Tapia; Katharina Glatz; Hedvika Novotny; Alessandro Lugli; Milo Horcic; Christian A Seemayer; Luigi Tornillo; Luigi Terracciano; Hanspeter Spichtin; Martina Mirlacher; Ronald Simon; Guido Sauter
Close association between HER-2 amplification and overexpression in human tumors of non-breast origin.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(2):192-8.
2007: Kristi Baker; Inti Zlobec; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass; Alessandro Lugli
Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.
European journal of cancer (Oxford, England : 1990) 2007;43(3):624-31.
2007: Alessandro Lugli; Inti Zlobec; Gad Singer; Andrea Kopp Lugli; Luigi Terracciano; Robert Genta
Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiology.
Nature clinical practice. Gastroenterology & hepatology 2007;4(1):52-7.
2007: Luigi Tornillo; Alessandro Lugli; Inti Zlobec; Niels Willi; Katharina Glatz; Frank Lehmann; Hans-Peter Spichtin; Robert Maurer; Dimitra Stoios; Guido Sauter; Luigi Terracciano
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
American journal of clinical pathology 2007;127(1):114-23.
2007: Annette Zimpfer; Sharon Schönberg; Alessandro Lugli; Claudio Agostinelli; Stefano A Pileri; Philip Thomas Went; Stephan Dirnhofer
Construction and validation of a bone marrow tissue microarray.
Journal of clinical pathology 2007;60(1):57-61.
2006: Alessandro Lugli; Inti Zlobec; Ursula Günthert; Parham Minoo; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(10):1302-9.
2006: Inti Zlobec; Russell Steele; René P Michel; Carolyn Corlies Compton; Alessandro Lugli; Jeremy R Jass
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(9):1236-42.
2006: Alessandro Lugli; Inti Zlobec; Parham Minoo; Kristi Baker; Luigi Tornillo; Luigi Terracciano; Jeremy R Jass
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
Human pathology 2006;37(8):1022-31.
2006: Alessandro Lugli; Jeremy R Jass
Types of colorectal adenoma.
Verhandlungen der Deutschen Gesellschaft für Pathologie 2006;90():18-24.
2005: Alessandro Lugli; Hanspeter Spichtin; Robert Maurer; Martina Mirlacher; Jeff Kiefer; Pia Huusko; David Azorsa; Luigi Terracciano; Guido Sauter; Olli Kallioniemi; Spyro Mousses; Luigi Tornillo
EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6450-8.
2005: Luigi Tornillo; Giacomo Duchini; Vincenza Carafa; Alessandro Lugli; Stephan Dirnhofer; Dolores Di Vizio; Amedeo Boscaino; Rosanna Russo; Coya Tapia; Regine Schneider-Stock; Guido Sauter; Luigi Insabato; Luigi Terracciano
Patterns of gene amplification in gastrointestinal stromal tumors (GIST).
Laboratory investigation; a journal of technical methods and pathology 2005;85(7):921-31.
2005: Alessandro Lugli; A Kopp Lugli; Milo Horcic
Napoleon's autopsy: new perspectives.
Human pathology 2005;36(4):320-4.
2005: Alessandro Lugli; Monika Ebnoether; Sergio B Cogliatti; Alois Gratwohl; Jakob Passweg; Urs Hess; Wolfgang C. Korte; Hanne Hawle; Marianne Tinguely; Bettina Borisch; Sara Mach-Pascual; Silke Von Juergensonn; André Tichelli; Stephan Dirnhofer
Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia.
Human pathology 2005;36(1):91-100.
2004: Philip Thomas Went; Stephan Dirnhofer; Marcel Bundi; Martina Mirlacher; Peter Schraml; Sara Mangialaio; Sasa Dimitrijevic; Juha Kononen; Alessandro Lugli; Ronald Simon; Guido Sauter
Prevalence of KIT expression in human tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4514-22.
2004: Alessandro Lugli; Luigi Tornillo; Martina Mirlacher; Marcel Bundi; Guido Sauter; Luigi Terracciano
Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
American journal of clinical pathology 2004;122(5):721-7.
2004: Annette Zimpfer; Philip Thomas Went; Alexandar Tzankov; Ann-Christine Pehrs; Alessandro Lugli; Robert Maurer; Luigi Terracciano; Stefano Pileri; Stephan Dirnhofer
Rare expression of KIT (CD117) in lymphomas: a tissue microarray study of 1166 cases.
Histopathology 2004;45(4):398-404.
2004: M Kühne; D Sidler; S Hofer; Alessandro Lugli; Ch Ludwig
Challenging manifestations of malignancies. Case 1. Polycythemia and high serum erythropoietin level as a result of hemangioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3639-40.
2004: Pia Huusko; Damaris Ponciano-Jackson; Maija Wolf; Jeff Kiefer; David Azorsa; Sukru Tuzmen; Don Weaver; Christiane Robbins; Tracy Y Moses; Minna Allinen; Sampsa Hautaniemi; Yidong Chen; Abdel G Elkahloun; Mark Basik; G Steven Bova; Lukas Bubendorf; Alessandro Lugli; Guido Sauter; Johanna Schleutker; Hilmi Ozcelik; Sabine Elowe; Tony Pawson; Jeffrey M. Trent; John D Carpten; Olli Kallioniemi; Spyro Mousses
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Nature genetics 2004;36(9):979-83.
2004: Luigi Tornillo; Holger Moch; Pierre-André Diener; Alessandro Lugli; Gad Singer
CDX-2 immunostaining in primary and secondary ovarian carcinomas.
Journal of clinical pathology 2004;57(6):641-3.
2004: Alessandro Lugli; Philip Thomas Went; B Khanlari; Z Nikolova; Stephan Dirnhofer
Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment.
Virchows Archiv : an international journal of pathology 2004;444(3):264-8.
2004: Philip Thomas Went; Alessandro Lugli; Sandra Meier; Marcel Bundi; Martina Mirlacher; Guido Sauter; Stephan Dirnhofer
Frequent EpCam protein expression in human carcinomas.
Human pathology 2004;35(1):122-8.
2004: Alessandro Lugli; Luigi Terracciano; Martin Oberholzer; Lukas Bubendorf; Luigi Tornillo
Macrofollicular variant of papillary carcinoma of the thyroid: a histologic, cytologic, and immunohistochemical study of 3 cases and review of the literature.
Archives of pathology & laboratory medicine 2004;128(1):54-8.
2003: B Khanlari; Andreas S Buser; Alessandro Lugli; André Tichelli; Stephan Dirnhofer
The expression pattern of CD56 (N-CAM) in human bone marrow biopsies infiltrated by acute leukemia.
Leukemia & lymphoma 2003;44(12):2055-9.
2003: Alexandar Tzankov; Annette Zimpfer; Ann-Christine Pehrs; Alessandro Lugli; Philip Thomas Went; Robert Maurer; Stefano Pileri; Stephan Dirnhofer
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(11):1141-7.
2003: Alessandro Lugli; Yvonne Forster; Philippe Haas; Antonio Nocito; christoph bucher; Heidi Bissig; Martina Mirlacher; Martina Storz; Michael J Mihatsch; Guido Sauter
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples.
Human pathology 2003;34(10):994-1000.
2003: Alexandar Tzankov; Ann-Christine Pehrs; Annette Zimpfer; Stefano Ascani; Alessandro Lugli; Stefano Pileri; Stephan Dirnhofer
Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.
Journal of clinical pathology 2003;56(10):747-52.
2003: Alexandar Tzankov; Annette Zimpfer; Alessandro Lugli; Jens Krugmann; Philip Thomas Went; Peter Schraml; Robert Maurer; Stefano Ascani; Stefano Pileri; Stephan Geley; Stephan Dirnhofer
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1.
The Journal of pathology 2003;199(2):201-7.
2002: Alessandro Lugli; F Stoffe; Luigi Terracciano; Stephan Dirnhofer; Michael J Mihatsch; Holger Moch
[Differentiated papillary kidney tumors. Differentiation between metanephric adenoma and papillary adenoma].
Der Pathologe 2002;23(4):303-7.
1999: Alessandro Lugli; M Anabitarte; J H Beer
Effect of simple interventions on necropsy rate when active informed consent is required.
Lancet 1999;354(9187):1391.